US Stocks
/
NextCure, Inc. Share Price

NextCure, Inc. Share Price

NASDAQ: NXTC | Micro Cap
$6.63
+$1.00 (17.64%) Last updated on 08 Oct, 2026 | 01:20 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NextCure, Inc. Stock Performance

Open
$6.34
Prev. Close
$5.64
Circuit Range
N/A
Day Range
$6.34 - $6.63
Year Range
$1.55 - $15.61
Volume
894
Average Traded
$6.54

NextCure, Inc. Share Price Today

As of 8 October 2026, NextCure, Inc.'s share price is $6.63. The stock opened at $6.34, compared to its previous close of $5.64. During today's trading session, NextCure, Inc.'s share price traded between $6.34 and $6.63, with an average price of $6.49. Over the past 52 weeks, the stock has recorded a high of $15.61 and a low of $1.55. In terms of performance, NextCure, Inc.'s share price has declined by 29.04% over the last six months and is down 47.22% on a year-on-year basis.

NextCure, Inc. Share Price Chart

$6.34$6.63
L
Show Current Price
H

NextCure, Inc. Stock Fundamentals & Key Indicators

Market Cap
$18.86M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-9.34
Revenue (TTM)
$0.00
Return On Equity (TTM)
-351.86%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-72.74%

NextCure, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.62-$9.44-$9.80-$14.89
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-9.51%-3.81%-51.94%

NextCure, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$74.73-$62.72-$55.65-$55.84
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A16.07%11.27%-0.34%

About NextCure, Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

NextCure, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$5.13
$6.63
+30.35%
Sep 2026
$6.51
$5.09
-16.35%
Aug 2026
$4.32
$6.08
+48.41%
Jul 2026
$1.85
$4.10
+149.24%
Jun 2026
$5.77
$1.65
-73.60%
May 2026
$9.80
$6.23
-33.37%
Apr 2026
$11.28
$9.35
-10.40%
Mar 2026
$12.19
$10.44
-20.95%
Feb 2026
$11.14
$13.20
+20.55%
Jan 2026
$13.43
$10.95
-23.80%
Dec 2025
$12.04
$14.37
+2.35%
Nov 2025
$9.53
$14.04
+11.69%

NXTC Share Price FAQs

What is NextCure, Inc. share price today?

chevron-up
NextCure, Inc. share price today is $6.63 as on October 8, 2026 at 1:20 am IST.

What is the 52 week high and 52 week low of NextCure, Inc. stock?

chevron-up
The 52 week high of NextCure, Inc. stock is $15.61, while the 52 week low is $1.55 as of 8 Oct '26.

What is NXTC's market capitalisation today?

chevron-up
NXTC market capitalisation is $18.86M as of October 8, 2026, at 4:08 pm IST.

What is NXTC's net income for the last quarter?

chevron-up
NXTC's net income for the last quarter is -14.89B USD.

What is the 5 year returns of NXTC?

chevron-up
The 5 year returns of NXTC is -19.28% as on 8 Oct '26.

What is the high & low stock price of NXTC today?

chevron-up
NXTC stock price hit a high of $6.63 and low of $6.34 as of 8 Oct '26.

Can I buy NXTC shares in India?

chevron-up
Yes. You can buy NXTC in India by opening an international trading account.